| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |